1. Large scale use of SARS-CoV-2 antigen-based detection tests: a three-month experience in Guatemala, June-August 2020
- Author
-
Antonio A. Paredes, Liz Parra, Jairo Mendez-Rico, Rafael A. León, Lorena Gobern, and Marc Rondy
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Emergency medicine ,Public Health, Environmental and Occupational Health ,Medicine ,Health organization ,business ,Predictive value - Abstract
Objectives To measure protocol adherence and antigen-based detection tests (AgDT) negative predictive value after 3 months of massive use as a diagnostic tool for COVID-19 in Guatemala Methods The study period included nasopharyngeal swabs taken between March 12 and August 31, 2020, which results were entered in the national COVID-19 information system Proportional increase in testing between one month before and one month after the introduction of AgDT (May 9–June 8 vs June 9–July 8) was measured Results After AgDT introduction, there was a 139% increase in SARS-CoV-2 testing Between June 9 and August 31, 7 8% of 110 657 AgDT-negative patients had follow-up RT-PCR testing Of them, 30% were RT-PCR positive Conclusions While introducing AgDT improved access to diagnostics, ensuring the availability of timely RT-PCR capacities to confirm diagnosis is also key © 2020 Pan American Health Organization All rights reserved
- Published
- 2020